Correvio Pharma Corporation (CORV) News

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199 ? 0.0 (0.00%)
Volume: 0 @-

$corv $0.4199

CORV stop trading what's up?

$corv $0.4199

$corv $0.4165

$corv $0.3946

$corv $0.39

$CORV EPS beat estimates. Analysts say HOLD. Short volume up in month of April. Loading some next week.

https://www.marketbeat.com/stocks/NASDAQ/CORV/price-target/

$corv $.4125

$corv $.3975

I’d be thrilled to see.42 before May.

$corv $.3902

$corv $.3713

$corv $1 with news

$CORV on the upswing

Would love to hear your target and why??

CORV should go up from here.

purchaser,advanz pharma 6.20pps TSX:ADVZ

CORonaVirus,hmmmm,interesting,did anyone else see that

accumulating>could be,good long,better company,debt paid off,shareholders happy,good times ahead for them as stock climbs daily on inked deal

their drug,cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia (CAP, HAP); Brinavess®
could be used to help cv19 patients

CORV is not shortable,so cant get shorted into oblivion if it runs up huge

reason bought for 76ml>The Company's portfolio of approved and marketed brands includes: Xydalba™ (dalbavancin hydrochloride), for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera®/Mabelio® (ceftobiprole medocaril sodium), a cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia (CAP, HAP); Brinavess® (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat® (tirofiban hydrochloride) for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome. Correvio's pipeline of product candidates includes Trevyent®, a drug device combination that is designed to deliver treprostinil, the world's leading treatment for pulmonary arterial hypertension.
this is coming> Brinavess New Drug was applied for fda approval(wonder if it is cv19 related)

trend is up,something is coming,inside peeps know what

Index - P/E - EPS (ttm) -0.90 Insider Own 0.80% Shs Outstand 54.93M Perf Week 9.44%
Market Cap 20.44M Forward P/E - EPS next Y -0.45 Insider Trans 0.00% Shs Float 54.20M Perf Month -19.11%
Income -36.70M PEG - EPS next Q -0.12 Inst Own 76.60% Short Float 8.41% Perf Quarter -20.83%
Sales 30.30M P/S 0.67 EPS this Y 29.50% Inst Trans -0.14% Short Ratio 0.63 Perf Half Y -83.39%
Book/sh 0.03 P/B 12.40 EPS next Y 44.30% ROA -60.90% Target Price 1.08 Perf Year -87.64%
Cash/sh 0.32 P/C 1.15 EPS next 5Y 28.00% ROE - 52W Range 0.21 - 3.22 Perf YTD -9.24%
Dividend - P/FCF - EPS past 5Y -26.80% ROI -16.30% 52W High -88.35% Beta 0.10
Dividend % - Quick Ratio 1.30 Sales past 5Y 44.80% Gross Margin 70.80% 52W Low 78.67% ATR 0.07
Employees 173 Current Ratio 1.50 Sales Q/Q -4.30% Oper. Margin -90.20% RSI (14) 52.14 Volatility 9.42% 15.81%
Optionable Yes Debt/Eq 29.33 EPS Q/Q -13.30% Profit Margin - Rel Volume 0.53 Prev Close 0.37
Shortable No LT Debt/Eq 22.07 Earnings Apr 08 BMO Payout - Avg Volume 7.22M Price 0.38
Recom 3.00 SMA20 0.85% SMA50 6.24% SMA200 -73.56% Volume 1,017,097 Change 0.84%

CORVette is a bolie rider,lots of run room,wiff of cv and boom!!

price crossed above 20 day sma,I am in,turn my 10k into 20k,thanks in advance

$corv $.355

Chart looks really good. Still don't understand why it has been trading so far away from the .42 buyout price. Looking for maybe a second offer to come in. Maybe that's why accumulation picked up today on some extra volume.

They have just been bought for .42 per share.

Why wouldn't it ?

Just exactly why would it go past .42?

You guys know a .38 break will send this crazy thing to blue skies right?

CORV Green now! That came out of nowhere. Still undervalued.

Wow, another CRASH and BURN!!!!!! Whoopsie!!!!!!

We see this all the time with Surge Holdings. Similar to Corevvio?

Spoken like a complete expert on bullshit. Thanks!

More Bullshit?

The time is hear we believe $CORV

I love how some folks lie to make themselves feel better about themselves....kind of sad really.